American Vanguard (AVD) Sets New 52-Week Low at $16.33

American Vanguard Corp. (NYSE:AVD) shares hit a new 52-week low during mid-day trading on Thursday . The company traded as low as $16.33 and last traded at $16.35, with a volume of 754 shares trading hands. The stock had previously closed at $17.12.

AVD has been the topic of a number of recent research reports. ValuEngine cut American Vanguard from a “buy” rating to a “hold” rating in a research note on Wednesday, August 8th. Zacks Investment Research upgraded shares of American Vanguard from a “sell” rating to a “hold” rating in a report on Tuesday, July 17th.

The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.89 and a current ratio of 2.05. The firm has a market capitalization of $545.84 million, a price-to-earnings ratio of 29.37 and a beta of 1.05.

American Vanguard (NYSE:AVD) last posted its earnings results on Monday, August 6th. The basic materials company reported $0.19 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.17 by $0.02. The company had revenue of $107.04 million during the quarter, compared to analyst estimates of $111.90 million. American Vanguard had a net margin of 5.45% and a return on equity of 6.29%. American Vanguard’s revenue for the quarter was up 37.4% on a year-over-year basis. During the same period in the prior year, the business posted $0.15 earnings per share. On average, analysts expect that American Vanguard Corp. will post 0.79 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which was paid on Wednesday, October 17th. Stockholders of record on Wednesday, October 3rd were issued a dividend of $0.02 per share. The ex-dividend date was Tuesday, October 2nd. This represents a $0.08 dividend on an annualized basis and a dividend yield of 0.49%. American Vanguard’s dividend payout ratio is currently 14.04%.

In other news, CFO David` T. Johnson sold 9,940 shares of the stock in a transaction dated Monday, July 23rd. The shares were sold at an average price of $20.91, for a total transaction of $207,845.40. Following the completion of the sale, the chief financial officer now directly owns 36,095 shares in the company, valued at $754,746.45. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Corporate insiders own 5.20% of the company’s stock.

A number of institutional investors and hedge funds have recently modified their holdings of the business. BlackRock Inc. lifted its holdings in American Vanguard by 5.3% in the second quarter. BlackRock Inc. now owns 3,922,354 shares of the basic materials company’s stock worth $90,018,000 after buying an additional 197,243 shares during the period. Bank of Montreal Can lifted its holdings in American Vanguard by 6.5% in the third quarter. Bank of Montreal Can now owns 595,922 shares of the basic materials company’s stock worth $10,728,000 after buying an additional 36,469 shares during the period. Northern Trust Corp lifted its holdings in American Vanguard by 1.5% in the second quarter. Northern Trust Corp now owns 345,052 shares of the basic materials company’s stock worth $7,919,000 after buying an additional 5,028 shares during the period. Principal Financial Group Inc. lifted its holdings in American Vanguard by 2.6% in the first quarter. Principal Financial Group Inc. now owns 205,454 shares of the basic materials company’s stock worth $4,150,000 after buying an additional 5,190 shares during the period. Finally, Schwab Charles Investment Management Inc. lifted its holdings in American Vanguard by 7.1% in the second quarter. Schwab Charles Investment Management Inc. now owns 143,736 shares of the basic materials company’s stock worth $3,299,000 after buying an additional 9,510 shares during the period. Institutional investors and hedge funds own 74.64% of the company’s stock.

American Vanguard Company Profile (NYSE:AVD)

American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. The company manufactures and formulates chemicals, including insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection.

See Also: Hedge Funds – Risk or Reward?

Receive News & Ratings for American Vanguard Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Vanguard and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply